| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Diabetes and Endocrinology, Scripps Clinic and Research Foundation La Jolla, California 92037 The Departments of Reproductive Medicine and Urology, School of Medicine, University of California San Diego, La Jolla, California 92037
Reprints: W. P. VanderLaan, M.D., Scripps Clinic and Research Foundation, 476 Prospect Street, La Jolla, California 92037.
A 76-year-old woman with virilization had menopausal levels of circulating LH and FSH, and a markedly elevated concentration of plasma testosterone (9130 pg/ml) into the range for adult men. Plasma cortisol and androstenedione levels and urinary 17-ketosteroid secretion were normal. Ethinyl estradiol suppressed plasma testosterone, LH, and FSH levels into the normal range for premenopausal women, but the testosterone concentration was unaffected by the administration of dexamethasone or ACTH. Retrograde venous sampling and angiography localized a right adrenal adenoma preoperatively. Following adrenalectomy, there was a prompt fall in testosterone, but there was no change in the LH concentration. Thus, this patient had an adrenal adenoma which secreted only testosterone and appeared to be gonadotropinresponsive. Testosterone levels in the adult male range failed to suppress gonadotropins. The significance of these findings is discussed.
Supported by grants from the Kroc Foundation, Santa Ynez, California 93460 and from the Rockefeller Foundation (RF-70029).
1 Present address: The Center for Endocrinology, Metabolism, and Nutrition, Northwestern University, Chicago, Illinois 60611.
Received March 10, 1975.
This article has been cited by other articles:
![]() |
S. Vuorenoja, B. P. Mohanty, J. Arola, I. Huhtaniemi, J. Toppari, and N. A Rahman Hecate-CG{beta} conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-{alpha} promoter Endocr. Relat. Cancer, June 1, 2009; 16(2): 549 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vuorenoja, A. Rivero-Muller, A. J Ziecik, I. Huhtaniemi, J. Toppari, and N. A Rahman Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin {beta} conjugate Endocr. Relat. Cancer, June 1, 2008; 15(2): 635 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome Endocr. Rev., February 1, 2001; 22(1): 75 - 110. [Abstract] [Full Text] |
||||
![]() |
T. C. Kamilaris, C. R. DeBold, K. J. Manolas, A. Hoursanidis, S. Panageas, and J. Yiannatos Testosterone-Secreting Adrenal Adenoma in a Peripubertal Girl JAMA, November 13, 1987; 258(18): 2558 - 2561. [Abstract] [PDF] |
||||
![]() |
G. E. Richards, M. D. Griffiths, D. J. Hoelzer, M. J. Kessler, M. Dan, R. N. Marshall, and L. E. Pottkotter Virilizing Adrenal Adenoma in a 2-Year-Old Girl: Analysis of Tumor Steroids Using High-Performance Liquid Chromatography Arch Pediatr Adolesc Med, August 1, 1983; 137(8): 741 - 744. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |